Disease focus Areas
We focus on addressing unmet medical needs in Oncology and Autoimmune diseases. Guided by deep insights into disease mechanisms, existing therapies, and target biology, we actively pursue the most effective paths to therapeutic innovation.
Rather than limiting ourselves to a single molecular modality, we select the optimal therapeutic approach based on scientific understanding of disease and target biology, leveraging our discovery platforms to efficiently generate clinical candidates with differentiated and best-in-class properties.
Autoimmunity & Inflammation
Building on clinically validated immunomodulatory mechanisms, Atheron designs innovative bifunctional molecules capable of simultaneously modulating multiple disease-relevant immune signaling pathways. By overcoming the limitations of single-target therapies, this approach enables synergistic efficacy in complex immune-mediated diseases.Our ultimate goal is to restore immune homeostasis and resolve pathological inflammation, delivering safer and more effective treatment options for patients worldwide living with RA, IBD, PsO, and other immune-mediated disorders.
Oncology
Atheron is dedicated to solid tumor oncology. We focus on novel mechanisms and emerging targets, especially those preciously considered undruggable, and leverage next-generation modalities to achieve superior clinical outcomes.
